SCHEMBL2806149

SCHEMBL2806149

COCCCOc1cc(CO)c2ccccc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.37
HPGD P15428 1/20 0.37
KMT2A Q03164 1/20 0.37
PPARG P37231 1/20 0.37
MAPK1 P28482 2/20 0.37
KDM4E B2RXH2 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
KCNA3 P22001 1/20 0.36
PDK2 Q15119 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
GPR88 Q9GZN0 1/20 0.36
ALDH1A1 P00352 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
AKR1B1 P15121 1/20 0.35
REN P00797 1/20 0.35
MTNR1A P48039 2/20 0.35
MTNR1B P49286 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13131325 0.88 HPGD (0.43) MEN1HPGDKMT2APPARGMAPK1
SCHEMBL2805447 0.87 NPC1 (0.38) MEN1HPGDKMT2APPARGMAPK1
SCHEMBL29151462 0.84 GRM5 (0.37) MEN1KMT2AKDM4ETDP1CYP1A2
SCHEMBL30747862 0.84 GRM5 (0.37) MEN1KMT2AKDM4ETDP1CYP1A2
SCHEMBL27774924 0.84 NPC1 (0.39) PPARGMAPK1KDM4ETDP1KCNA3
SCHEMBL8965862 0.80 AKR1B1 (0.50) MEN1KMT2ATDP1CYP1A2AKR1B1
SCHEMBL27795801 0.80 NQO1 (0.44) HPGDPPARGMAPK1KDM4ETDP1
SCHEMBL2810252 0.79 ALDH1A1 (0.37) MEN1HPGDKMT2APPARGKDM4E
SCHEMBL25016929 0.79 RHEB (0.49) PPARGNPC1RAB9AAKR1B1
SCHEMBL8818397 0.76 RECQL (0.48) MEN1HPGDKMT2AMAPK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2168952-B1 MORPHOLINE DERIVATIVES AS RENIN INHIBITORS MITSUBISHI TANABE PHARMA CORP (JP) 2017-02-15 EP disclosed
US-8975252-B2 Morpholine derivative SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) 2015-03-10 US disclosed
US-20100240644-A1 MORPHOLINE DERIVATIVE SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) 2010-09-23 US disclosed
EP-2168952-A1 MORPHOLINE DERIVATIVE Mitsubishi Tanabe Pharma Corporation (JP) 2010-03-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240644-A1 MORPHOLINE DERIVATIVE REN, AGTR1, AGTR2 MEN1 167/4885HPGD 1835/4885KMT2A 1278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.